Filters: Author is Fiellin, David A [Clear All Filters]
"Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors." Journal of substance abuse treatment 35, no. 1 (2008): 87-92. Abstract
"Brief intervention for hazardous and harmful drinkers in the emergency department." Annals of emergency medicine 51, no. 6 (2008): 742-750.e2. Abstract
"Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 17, no. 2 (2008): 116-20. Abstract
"Narrative review: buprenorphine for opioid-dependent patients in office practice." Annals of internal medicine 148, no. 9 (2008): 662-70. Abstract
"Treatment of adolescent opioid dependence: no quick fix." JAMA : the journal of the American Medical Association 300, no. 17 (2008): 2057-9.
"The association between chronic pain and prescription drug abuse in Veterans." Pain medicine (Malden, Mass.) 10, no. 3 (2009): 531-6. Abstract
"Factors affecting willingness to provide buprenorphine treatment." Journal of substance abuse treatment 36, no. 3 (2009): 244-51. Abstract
"Integrating buprenorphine treatment into office-based practice: a qualitative study." Journal of general internal medicine 24, no. 2 (2009): 218-25. Abstract
"Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients." Drug and alcohol dependence 99, no. 1-3 (2009): 132-40. Abstract
"Depression symptoms and treatment among HIV infected and uninfected veterans." AIDS and behavior 14, no. 2 (2010): 272-9. Abstract
"Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?" Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 13, no. 5 (2010): 535-42. Abstract
"Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort." Drug and alcohol dependence 110, no. 3 (2010): 208-20. Abstract
"The case for routine HIV screening and impact of managed care." The American journal of managed care 16, no. 13 Suppl (2010): S345-51. Abstract
"Opioids, chronic pain, and addiction in primary care." The journal of pain : official journal of the American Pain Society 11, no. 12 (2010): 1442-50. Abstract
"Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV-infected and HIV-uninfected men." Journal of general internal medicine 25, no. 2 (2010): 115-21. Abstract
"The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 19, no. 1 (2010): 53-8. Abstract
"Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone." Journal of general internal medicine 25, no. 7 (2010): 670-4. Abstract
"Opioid doses and increased risk for overdose." Annals of internal medicine 153, no. 1 (2010): 59; author reply 59-60.
"Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial." Annals of internal medicine 152, no. 11 (2010): 704-11. Abstract
"Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial." Addictive behaviors 35, no. 5 (2010): 537-40. Abstract
"Substance use in patients with sexually transmitted infections: results from a national U.S. survey." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 19, no. 6 (2010): 504-9. Abstract
"The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment." Journal of general internal medicine 25, no. 9 (2010): 936-41. Abstract
"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial." Archives of general psychiatry 68, no. 12 (2011): 1238-46. Abstract
"State variation in AIDS drug assistance program prescription drug coverage for modifiable cardiovascular risk factors." Journal of general internal medicine 26, no. 12 (2011): 1426-33. Abstract
"Adding buprenorphine implants to counselling reduces opioid use over 6 months in opioid-dependent adults." Evidence-based mental health 14, no. 1 (2011): 30.
"A meta-analysis of the efficacy of nonphysician brief interventions for unhealthy alcohol use: implications for the patient-centered medical home." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 20, no. 4 (2011): 343-56. Abstract
"Cost and utilization outcomes of opioid-dependence treatments." The American journal of managed care 17 Suppl 8 (2011): S235-48. Abstract
"Nonmedical use of opioid analgesics obtained directly from physicians: prevalence and correlates." Archives of internal medicine 171, no. 11 (2011): 1034-6.
"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S33-8. Abstract
"Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S14-21. Abstract
"The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S7-13. Abstract
"The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S76-82. Abstract
"Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S62-7. Abstract
"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S22-32. Abstract
"The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S54-61. Abstract
"Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S39-45. Abstract
"Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S83-90. Abstract
"Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S68-75. Abstract
"Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S91-7. Abstract
"Nonmedical use of prescription opioids and pain in veterans with and without HIV." Pain 152, no. 5 (2011): 1133-8. Abstract
"Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medications." Journal of general internal medicine 26, no. 9 (2011): 1012-8. Abstract
"Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection." Drug and alcohol dependence 117, no. 2-3 (2011): 158-63. Abstract
"Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?" Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 54, no. 7 (2012): 984-94. Abstract
"Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone." Journal of addiction medicine 6, no. 4 (2012): 274-9. Abstract
"Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone." Alcoholism, clinical and experimental research 36, no. 2 (2012): 318-24. Abstract
"Human Immunodeficiency Virus-Testing Practices Among Buprenorphine-prescribing Physicians." Journal of addiction medicine (2012). Abstract
"Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals." Drugs 72, no. 2 (2012): 217-28. Abstract
"Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care." Journal of general internal medicine (2012). Abstract
"Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents." Drug and alcohol dependence (2012). Abstract
"Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment." Drug and alcohol dependence (2012). Abstract
